FENNEC PHARMACEUTICALS INC. (FENC) › Net IncomeFENNEC PHARMACEUTICALS INC. (FENC) — Net IncomeAnnual figures by fiscal year, from SEC filings.1998: -$398.0K1999: -$958.0K2000: -$1.60M2001: -$2.52M2002: -$3.73M2003: -$17.80M2004: -$6.87M2005: -$13.87M2006: -$16.44M2007: -$13.36M2008: -$13.60M2009: -$3.01M2010: -$7.82M2011: $4.68M2012: -$5.16M2013: $1.84M2014: -$2.18M2015: -$659.0K2016: -$2.79M2017: -$7.05M2018: -$9.89M2019: -$12.78M2020: -$18.11M2021: -$17.35M2022: -$23.71M2023: -$16.05M2024: -$436.0K2025: -$9.74M-$9.74M1998Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$9.74M-2134.2%2024-$436.0K+97.3%2023-$16.05M+32.3%2022-$23.71M-36.7%2021-$17.35M+4.2%2020-$18.11M-41.8%2019-$12.78M-29.2%2018-$9.89M-40.3%2017-$7.05M-152.6%2016-$2.79M-323.2%2015-$659.0K+69.7%2014-$2.18M-217.9%2013$1.84M+135.7%2012-$5.16M-210.2%2011$4.68M+159.9%2010-$7.82M-159.7%2009-$3.01M+77.9%2008-$13.60M-1.8%2007-$13.36M+18.8%2006-$16.44M-18.5%2005-$13.87M-101.8%2004-$6.87M+61.4%2003-$17.80M-376.8%2002-$3.73M-47.9%2001-$2.52M-57.3%2000-$1.60M-67.5%1999-$958.0K-140.7%1998-$398.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share